• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Type 2 Asthma Learning Hub
    • Atopic Dermatitis Learning Hub
    • Bullous Pemphigoid Learning Hub
    • COPD Learning Hub
    • Prurigo Nodularis Learning Hub
    • Rhinology Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Your Catalyst Learning Hub: Advancing Respiratory Treatment Paradigms
    • Your Navigator Learning Hub: Guiding Personalized Patient Journeys
    • Your Steward Learning Hub: Upholding Excellence in Everyday Practice
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Dynamic Eosinophils: Decoding Variability in COPD
Pulmonology
5 min
interactivity

Dynamic Eosinophils: Decoding Variability in COPD

ERS 2026 | Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma
Pulmonology
35 min
expert video

ERS 2026 | Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma

ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease
Pulmonology
35 min
expert video

ERS 2026 | Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease

Expert Insights on the Management of Bullous Pemphigoid: The Canadian Treatment Guidelines
Dermatology
5 min
expert video

Expert Insights on the Management of Bullous Pemphigoid: The Canadian Treatment Guidelines

Expert Insights on the Burden of Bullous Pemphigoid
Dermatology
5 min
expert video

Expert Insights on the Burden of Bullous Pemphigoid

EoE Quest: Navigating the Patient Experience
Gastroenterology
12 min
interactivity

EoE Quest: Navigating the Patient Experience

Antihistamines in the Treatment of CSU
Dermatology
20 min
Infographic

Antihistamines in the Treatment of CSU

Beyond the Assumptions: Differentiating the Evidence on AD Pathomechanisms
Dermatology
25 min
expert video

Beyond the Assumptions: Differentiating the Evidence on AD Pathomechanisms

Clarifying CSU: Separating Facts From Misconceptions
Dermatology
25 min
expert video

Clarifying CSU: Separating Facts From Misconceptions

From Itch to Lesions: The Type 2 Inflammatory Link in AD, PN, and CSU
Dermatology
25 min
expert video

From Itch to Lesions: The Type 2 Inflammatory Link in AD, PN, and CSU

Correcting the Narrative: Dispelling Persistent Misconceptions About PN
Dermatology
25 min
expert video

Correcting the Narrative: Dispelling Persistent Misconceptions About PN

Challenging Assumptions: Clarifying Type 2 Inflammation Across AD, PN, and CSU
Dermatology
60 min
expert video

Challenging Assumptions: Clarifying Type 2 Inflammation Across AD, PN, and CSU

    1234
    ...
    21